IQV
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
35.37B
GET INTRADAY SIGNALS
IQV Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
40 days until earnings call
+Compare
IQV
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
35.37B

IQV IQVIA Holdings Forecast, Technical & Fundamental Analysis

a provider of biopharmaceutical development services and commercial outsourcing services

GET INTRADAY SIGNALS
IQV Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Mar 23, 2023

IQV in downward trend: 10-day moving average broke below 50-day moving average on February 28, 2023

The 10-day moving average for IQV crossed bearishly below the 50-day moving average on February 28, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 09, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on IQV as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

IQV moved below its 50-day moving average on March 07, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IQV entered a downward trend on March 23, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IQV's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .

IQV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IQV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.072) is normal, around the industry mean (16.026). P/E Ratio (32.895) is within average values for comparable stocks, (182.825). Projected Growth (PEG Ratio) (1.349) is also within normal values, averaging (5.799). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (2.487) is also within normal values, averaging (59.834).

AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.25B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 9%. ENZ experienced the highest price growth at 79%, while AZYO experienced the biggest fall at -67%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -93%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 56
SMR Rating: 82
Profit Risk Rating: 85
Seasonality Score: 4 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published Earnings

IQV is expected to report earnings to fall 13.31% to $2.41 per share on May 03

IQVIA Holdings IQV Stock Earnings Reports
Q1'23
Est.
$2.41
Q4'22
Beat
by $0.02
Q3'22
Beat
by $0.09
Q2'22
Beat
by $0.06
Q1'22
Beat
by $0.05
The last earnings report on February 10 showed earnings per share of $2.78, beating the estimate of $2.76. With 2.27M shares outstanding, the current market capitalization sits at 35.37B.
AI
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical development services and commercial outsourcing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2400 Ellis Road
Phone
+1 919 998-2000
Employees
86000
Web
https://www.iqvia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIAN1.700.05
+3.03%
LianBio
DOV140.53-0.01
-0.01%
Dover Corp
WLKP21.65-0.26
-1.19%
Westlake Chemical Partners LP
SEAC0.38-0.01
-2.06%
SeaChange International
PR9.48-0.29
-2.97%
Permian Resources Corp

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with ICLR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then ICLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-1.06%
ICLR - IQV
87%
Closely correlated
-0.37%
TMO - IQV
79%
Closely correlated
+0.16%
MTD - IQV
78%
Closely correlated
-0.08%
DHR - IQV
77%
Closely correlated
+0.25%
PKI - IQV
76%
Closely correlated
+0.01%
More

Groups containing IQV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-1.06%
IQV
(undefined stocks)
90%
Closely correlated
-0.17%
innovating biotech
(undefined stocks)
84%
Closely correlated
+0.38%
outsourcing
(undefined stocks)
81%
Closely correlated
-0.40%
biotechnology
(undefined stocks)
79%
Closely correlated
-0.07%
health
(undefined stocks)
76%
Closely correlated
-0.59%